 |
|
Gene's discovery could help prevent a leading cause of blindness in the elderly
August 17, 2005University of Pittsburgh researchers have discovered a gene linked to age-related maculopathy (ARM), the leading cause of untreatable blindness in the elderly. Their discovery suggests a simple test might be able to identify those at risk for what is commonly known as macular degeneration (AMD) and may lead to the development of more effective preventive strategies.
Researchers report that variations of a gene called PLEKHA1 are strongly associated with a person's risk of developing ARM. The results, a culmination of 15 years of research, will be published in the September issue of the American Journal of Human Genetics and are currently available online.
The discovery of the gene came about through the team's efforts to map the genes of 612 families affected by ARM and an additional 323 individuals without a history of macular degeneration. Pooling data from a number of gene mapping studies, researchers were able to identify multiple locations on the chromosomes where there are common gene variants among people with ARM. Specifically, researchers found that a region on one of these chromosomes, chromosome 10, was the one most likely to contain a major gene that influences the risk of ARM. Further analysis of chromosome 10 found that a variation in PLEKHA1 to be strongly associated with a person's risk of developing ARM.
Earlier this year, researchers from Rockefeller University, Yale University, The National Eye Institute, Duke University, Vanderbilt University, University of Texas Southwestern, and Boston University used similar methods to identify the first gene variant thought to be a major contributor to ARM, complement factor H (CFH) on chromosome 1. The Pittsburgh study confirms involvement of this gene and, for the first time, shows that the association results also accounted for findings from previous genetic studies of AMD families. Importantly, the new study found that having both CFH and PLEKHA1 indicate a greater risk for macular degeneration.
"CFH was the first piece of the puzzle," said Michael Gorin, M.D., Ph.D., professor of ophthalmology, University of Pittsburgh School of Medicine, and professor of human genetics, University of Pittsburgh Graduate School of Public Health. "To fully understand the pathology of macular degeneration, we knew we needed to expand our investigation to find all of the genes that play a part in this condition. PLEKHA1 is an important second piece, and we'll keep searching for the rest of the pieces until we get this solved."
By identifying a number of genetic variants for ARM, researchers hope to use this information to develop a simple set of DNA tests to identify individuals who are at increased risk of this sight-robbing condition. Additionally, they hope to develop new preventive strategies and a better understanding of how ARM occurs.
An important clue to understanding the cause and mechanism of ARM was revealed through this discovery. PLEKHA1, like CFH, is involved in the cellular processes related to inflammation, which supports the hypothesis that damage caused by ARM is, in part, due to inflammation.
ARM is the leading cause of untreatable blindness in the elderly and despite recent advances in the treatment of some forms of this condition, it continues to be a serious threat to vision with no known cure. An estimated 200,000 Americans develop a severe form of AMD each year, making it the leading cause of blindness in people aged 65 and older. As many as 30 percent of individuals over the age of 75 have evidence of macular degenerative changes.
In addition to Dr. Gorin, contributing authors to this study are Johanna Jakobsdottir, graduate student in the department of biostatistics, Graduate School of Public Health (GSPH); Tammy Mah, department of ophthalmology, School of Medicine; Daniel Weeks, Ph.D., professor in the departments of human genetics and biostatistics, GSPH; Robert Ferrell, Ph.D., professor in the department of human genetics, GSPH; and Yvette Conley, Ph.D., assistant professor in the department of health promotion and development, School of Nursing, and assistant professor in the department of human genetics, GSPH.
University of Pittsburgh Medical Center
Earlier this year, researchers from Rockefeller University, Yale University, The National Eye Institute, Duke University, Vanderbilt University, University of Texas Southwestern, and Boston University used similar methods to identify the first gene variant thought to be a major contributor to ARM, complement factor H (CFH) on chromosome 1. The Pittsburgh study confirms involvement of this gene and, for the first time, shows that the association results also accounted for findings from previous genetic studies of AMD families. Importantly, the new study found that having both CFH and PLEKHA1 indicate a greater risk for macular degeneration.
"CFH was the first piece of the puzzle," said Michael Gorin, M.D., Ph.D., professor of ophthalmology, University of Pittsburgh School of Medicine, and professor of human genetics, University of Pittsburgh Graduate School of Public Health. "To fully understand the pathology of macular degeneration, we knew we needed to expand our investigation to find all of the genes that play a part in this condition. PLEKHA1 is an important second piece, and we'll keep searching for the rest of the pieces until we get this solved."
By identifying a number of genetic variants for ARM, researchers hope to use this information to develop a simple set of DNA tests to identify individuals who are at increased risk of this sight-robbing condition. Additionally, they hope to develop new preventive strategies and a better understanding of how ARM occurs.
An important clue to understanding the cause and mechanism of ARM was revealed through this discovery. PLEKHA1, like CFH, is involved in the cellular processes related to inflammation, which supports the hypothesis that damage caused by ARM is, in part, due to inflammation.
ARM is the leading cause of untreatable blindness in the elderly and despite recent advances in the treatment of some forms of this condition, it continues to be a serious threat to vision with no known cure. An estimated 200,000 Americans develop a severe form of AMD each year, making it the leading cause of blindness in people aged 65 and older. As many as 30 percent of individuals over the age of 75 have evidence of macular degenerative changes.
In addition to Dr. Gorin, contributing authors to this study are Johanna Jakobsdottir, graduate student in the department of biostatistics, Graduate School of Public Health (GSPH); Tammy Mah, department of ophthalmology, School of Medicine; Daniel Weeks, Ph.D., professor in the departments of human genetics and biostatistics, GSPH; Robert Ferrell, Ph.D., professor in the department of human genetics, GSPH; and Yvette Conley, Ph.D., assistant professor in the department of health promotion and development, School of Nursing, and assistant professor in the department of human genetics, GSPH.
University of Pittsburgh Medical Center
Blindness Current Events and Blindness News RSSVaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission
Most successful vaccines and drugs rely on protecting humans or animals by blocking certain bacteria from growing in their systems. But, a new theory actually hopes to take stopping infectious diseases such as West Nile virus and Malaria to the next level by disabling insects from transmitting these viruses.
New technique captures high-res images of full retina
Researchers used a new imaging technique to take high quality color photographs of the clinical stages of ocular inflammation in mice, and the technology could help in the monitoring and treatment of diseases of the eye that may cause blindness.
Drivers make more errors when talking on cell phone than to a passenger
Drivers make more mistakes when talking on a cell phone than when talking to passengers, new research shows.
Carnegie Mellon scientists offer explanation for 'face blindness'
For the first time, scientists have been able to map the disruption in neural circuitry of people suffering from congenital prosopagnosia, sometimes known as face blindness, and have been able to offer a biological explanation for this intriguing disorder.
Melatonin may save eyesight in inflammatory disease
Current research suggests that melatonin therapy may help treat uveitis, a common inflammatory eye disease. The related report by Sande et al., "Therapeutic Effect of Melatonin in Experimental Uveitis," appears in the December issue of The American Journal of Pathology.
Conference report highlights new research into drug delivery to treat eye disease
Researchers are investigating microneedles, nanoparticles and polymer carriers as potential new techniques to combat the leading cause of visual impairment and blindness in the United States, according to a report from the Third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.
Eye conditions linked with obstructive sleep apnea
If a good night's sleep helps the brain and body perform better, it's a good guess that sleep problems can cause more than just fatigue. Numerous studies have shown a connection between sleep disorders and medical conditions such as cardiovascular disease, cerebrovascular disease, and metabolic disorders, including the risk of obesity and diabetes mellitus. In the November issue of Mayo Clinic Proceedings, Mayo Clinic researchers outline several interesting associations between sleep disorders and eye disease.
Researchers find aggressive phototherapy can improve neurodevelopmental outcomes in some preemies
Researchers at The University of Texas Medical School at Houston say the use of aggressive phototherapy reduces the odds that tiny premature infants will develop neurodevelopmental impairment such as cerebral palsy, blindness, deafness or physical or mental challenges.
Contact lenses are home to pathogenic amoebae
Contact lenses increase the risk of infection with pathogenic protozoa that can cause blindness.
Man's best friend recruited in the hunt for disease genes
For centuries man has had a uniquely close relationship with dogs - as a working animal, for security and, perhaps most importantly, for companionship. Now, dogs are taking on a new role - they are helping in the hunt for genetic mutations that lead to diseases in humans.
More Blindness Current Events and Blindness News Articles
 | Blindness (Movie Tie-In) by Jose Saramago NOW A MAJOR MOTION PICTURE A city is hit by an epidemic of "white blindness" that spares no one. Authorities confine the blind to an empty mental hospital, but there the criminal element holds everyone captive, stealing food rations and assaulting women. There is one eyewitness to this nightmare who guides seven strangers—among them a boy with no mother, a girl with dark glasses, a dog of... |
 | Willful Blindness: Memoir of the Jihad by Andrew C. McCarthy Andrew C. McCarthy takes readers back to the real beginning of the war on terror--not the atrocities of September 11, but the first bombing of the World Trade Center in February 1993 when radical Islamists effectively declared war on the United States. From his perch as a government prosecutor of the blind sheik and other jihadists responsible for the bombing, Andrew McCarthy takes readers inside... |
 | Blindness by Saramago Jose A city is hit by an epidemic of "white blindness" which spares no one. Authorities confine the blind to an empty mental hospital, but there the criminal element holds everyone captive, stealing food rations and raping women. There is one eyewitness to this nightmare who guides seven strangers-among them a boy with no mother, a girl with dark glasses, a dog of tears-through the barren streets, and... |
 | Inattentional Blindness by Arien Mack, Irvin Rock Many people believe that merely by opening their eyes, they see everything in their field of view. In Inattentional Blindness, Arien Mack and Irvin Rock make the radical claim that there is no conscious perception of the visual world without attention to it. The phenomenon of inattentional blindness has theoretical importance for cognitive psychologists studying perception, attention, and ... |
| Blindness by Jose Saramago | |
 | The Year of the Death of Ricardo Reis, the Gospel According to Jesus Christ, Blindness by Jose Saramago |
 | Willful Blindness: The Bush Administration and Iraq by Trudy Rubin Just weeks before a presidential election in which Iraq is the hottest issue, one of America's sharpest foreign affairs commentators lays out how the Bush team marched with eyes wide shut into a quagmire. In her Worldview column for The Philadelphia Inquirer, Trudy Rubin predicted what would happen, warned about the mistakes on the ground, advised what should be done, and pointed out who made... |
 | Blindness and Insight: Essays in the Rhetoric of Contemporary Criticism (Theory & History of Literature) by Paul De Man |
 | A Psychologist Looks at Blindness by Allan Dodds This book is intended to form a core textbook in the graduate training courses for Rehabilitation Workers with blind people. It covers literary, sociological and psychological perspectives on acquired blindness and offers a modern antidote to dated texts which still dominate the... |
 | Change Blindness and Visual Memory by Daniel Simons (Psychology Press) Harvard Univ., Boston, MA. Reprint of the journal 'Visual Cognition', Vol. 7, issues 1, 2, and 3. Unites studies of change blindness with studies of visual memory. Graphs, photos, and tables. Multiple international... |
| © 2008 BrightSurf.com |